Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | BCHE | P06276 | 7/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1022593 | 1.00 | HDAC6 (0.58) | HDAC6BCHEMAOAMEN1MAPT | |
| SCHEMBL23057479 | 0.94 | HDAC6 (0.54) | HDAC6BCHEMAOAMEN1MAPT | |
| SCHEMBL29851224 | 0.89 | HDAC6 (0.62) | HDAC6BCHEMAOAMEN1KMT2A | |
| SCHEMBL12190901 | 0.89 | HDAC6 (0.62) | HDAC6BCHEMAOAMEN1KMT2A | |
| SCHEMBL24024212 | 0.86 | HDAC6 (0.50) | HDAC6BCHEMAOAMEN1MAPT | |
| SCHEMBL28407558 | 0.84 | HDAC6 (0.48) | HDAC6BCHEMAOAMEN1MAPT | |
| SCHEMBL15470433 | 0.84 | HDAC6 (0.48) | HDAC6BCHEMAOAMEN1MAPT | |
| SCHEMBL15470447 | 0.83 | HDAC6 (0.57) | HDAC6BCHEMAOAMEN1KMT2A | |
| SCHEMBL342426 | 0.83 | HDAC6 (0.56) | HDAC6BCHEMAOAMEN1KMT2A | |
| SCHEMBL29387100 | 0.83 | HDAC6 (0.56) | HDAC6BCHEMAOAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119899395-A | Preparation method and application of copper cluster-phenothiazinyl metal organic framework with visible light catalytic C-N bond cross-coupling performance | 大连理工大学 | 2025-04-29 | — | — | CN | claimed |
| EP-3806176-B1 | ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2025-06-25 | — | — | EP | disclosed |
| CN-120058638-A | Preparation method of phenothiazine derivative for generating singlet oxygen | 合肥大学 | 2025-05-30 | — | — | CN | disclosed |
| CN-119899395-A | Preparation method and application of copper cluster-phenothiazinyl metal organic framework with visible light catalytic C-N bond cross-coupling performance | 大连理工大学 | 2025-04-29 | — | — | CN | disclosed |
| CN-113292514-B | Piperazine derivative and organic photoelectric device comprising same | 浙江华显光电科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| US-11245079-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2022-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11245079-B2 | Materials for organic electroluminescent devices | OR10J3, L1CAM, EPCAM | HDAC6 4524/4885BCHE 658/4885MAOA 315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.